Positron Emission Tomography Imaging of Hepatocellular Carcinoma with Radiolabeled Choline

Positron Emission Tomography Imaging of Hepatocellular Carcinoma with Radiolabeled Choline

Bibliographic Details
Main Author:	Kuang, Yu
Language:	English
Published:	Case Western Reserve University School of Graduate Studies / OhioLINK 2009
Subjects:	Biochemistry Engineering Health Radiology Scientific Imaging Hepatocellular Carcinoma Positron Emission Tomography (PET) [<sup>11</sup>C]-choline Molecular imaging FDG Cancer Metabolism Transport mechanism Phosphatidylcholine synthesis Lipids High performance liquid chromatography
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=case1238781224

Similar Items

Choline PET/CT in Multiple Myeloma
by: Charles Mesguich, et al.
Published: (2020-05-01)

Prognostic Value of Metabolic Imaging Data of <sup>11</sup>C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
by: Matteo Donadon, et al.
Published: (2021-01-01)

Positron Emission Tomography in Merkel Cell Carcinoma
by: Christos Sachpekidis, et al.
Published: (2020-10-01)

Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous
by: Maria Vittoria Mattoli, et al.
Published: (2020-09-01)

Synthesis and Biological Evaluation of a Radiolabeled PET (Positron Emission Tomography) Probe for Visualization of In Vivo α-Fucosidase Expression
by: Jonathan Cotton, et al.
Published: (2021-07-01)

The Role of Positron Emission Tomography/Computed Tomography (PET/CT) for Staging and Disease Response Assessment in Localized and Locally Advanced Pancreatic Cancer
by: Michele Ghidini, et al.
Published: (2021-08-01)

Diagnostic Value of Choline PET in the Preoperative Localization of Hyperfunctioning Parathyroid Gland(s): A Comprehensive Overview
by: Cristina Ferrari, et al.
Published: (2021-02-01)

Relationship between Standard Uptake Values of Positron Emission Tomography/Computed Tomography and Salivary Metabolites in Oral Cancer: A Pilot Study
by: Shigeo Ishikawa, et al.
Published: (2020-12-01)

11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
by: Kazuhiro Kitajima, et al.
Published: (2016-11-01)

The Role of [<sup>18</sup>F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [<sup>11</sup>C]Choline PET/CT and Histopathological Analysis
by: Lucia Zanoni, et al.
Published: (2021-03-01)

Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
by: Zbynek Novy, et al.
Published: (2019-07-01)

Simultaneous Recording of the Uptake and Conversion of Glucose and Choline in Tumors by Deuterium Metabolic Imaging
by: Andor Veltien, et al.
Published: (2021-08-01)

<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis
by: Joon Young Choi, et al.
Published: (2018-12-01)

Quantitative FDG PET Assessment for Oncology Therapy
by: Kenji Hirata, et al.
Published: (2021-02-01)

Prediction Model for Tumor Budding Status Using the Radiomic Features of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cervical Cancer
by: Gun Oh Chong, et al.
Published: (2021-08-01)

Prognostic Value of <sup>18</sup>F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
by: Luca Filippi, et al.
Published: (2020-11-01)

If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[<sup>18</sup>F]FDG Metabolism
by: Eva-Maria Klebermass, et al.
Published: (2021-09-01)

<sup>18</sup>F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
by: Nicoletta Urbano, et al.
Published: (2019-10-01)

PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
by: Tae Sup Lee, et al.
Published: (2018-10-01)

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and <sup>18</sup> F-choline PET/CT
by: Vees Hansjörg, et al.
Published: (2012-08-01)

The Additional Value of <sup>18</sup>F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
by: Natale Quartuccio, et al.
Published: (2020-05-01)

A phase II study for metabolic <it>in vivo </it>response monitoring with sequential <sup>18</sup>FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
by: Berger Anne, et al.
Published: (2012-03-01)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
by: Christos Sachpekidis, et al.
Published: (2019-12-01)

The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an <sup>18</sup>F-FDG PET/CT Study in the Tropics
by: Huang Yung-Cheng, et al.
Published: (2011-12-01)

Clinical Utility of <sup>18</sup>F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
by: Emmanouil Alevroudis, et al.
Published: (2021-04-01)

C-11 Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma – a Comparative Analysis
by: Chanisa Chotipanich, et al.
Published: (2015-01-01)

C-11 Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma – a Comparative Analysis
by: Chanisa Chotipanich, et al.
Published: (2015-01-01)

Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
by: Masoud Sadeghzadeh, et al.
Published: (2020-05-01)

Histiocytic Sarcoma: Challenging Course, Dismal Outcome
by: Kim Francis Andersen, et al.
Published: (2021-02-01)

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by <sup>18</sup>F-FDG PET/CT
by: Artor Niccoli Asabella, et al.
Published: (2021-02-01)

Diabetic Foot Infections: The Diagnostic Challenges
by: Chiara Lauri, et al.
Published: (2020-06-01)

Imaging Inflammation with Positron Emission Tomography
by: Janette Iking, et al.
Published: (2021-02-01)

2-[<sup>18</sup> F]fluoro-2-deoxy-<smcaps>d</smcaps>-glucose (FDG) positron-emission tomography (PET) findings of chronic expanding intrapericardial hematoma: a potential interpretive pitfall that mimics a malignant tumor
by: Tokue Hiroyuki, et al.
Published: (2013-01-01)

<sup>18</sup>F-fluoroethyltyrozine positron emission tomography combined with computed tomography and computed tomography perfusion in complex diagnostic of glial brain tumors
by: A. I. Pronin, et al.
Published: (2020-02-01)

The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01)

2-[<sup>18</sup>F]FDG PET/CT as a Predictor of Microvascular Invasion and High Histological Grade in Patients with Hepatocellular Carcinoma
by: Aida Sabaté-Llobera, et al.
Published: (2021-05-01)

Phosphatidylcholine from krill increases plasma choline and its metabolites in dogs
by: Lena Burri, et al.
Published: (2019-05-01)

Can the Efficacy of [<sup>18</sup>F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
by: Hazel O’Neill, et al.
Published: (2019-01-01)

Lyme Neuroborreliosis in a Patient with Breast Cancer: MRI and PET/CT Findings
by: Mathilde Ørbæk, et al.
Published: (2020-01-01)

Place of the <sup>18</sup>F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)
by: Simon Letertre, et al.
Published: (2021-08-01)